Navigation Links
Plugging in molecular wires
Date:2/12/2009

This release is available in German.

Plants, algae, and cyanobacteria (blue-green algae) are masters of everything to do with solar energy because they are able to almost completely transform captured sunlight into chemical energy. This is in part because the electrons set free by the photons are transported out of the "light receptor" 1:1 to be used as the driving force for chemical reactions. Japanese researchers have now developed a new process to capture light energy with nearly equal efficiency. As they report in the journal Angewandte Chemie, they "plug" a molecular "wire" directly into a biological photosynthetic system to efficiently conduct the free electrons to a gold electrode.

The efficiency of photovoltaic energy conversion is of critical significance for the practical application of solar installations. Theoretically, every photon absorbed should release one electron. Whereas modern solar cells are far from achieving high efficiency, natural photosynthetic systems achieve nearly 100 % quantum yield. To improve the efficiency of synthetic systems, experiments were attempted in which biological light-capturing units were deposited onto electrodes as thin films. However, the transfer of electrons from the light-capturing layer into the circuit in this type of system is so inefficient that most of the electrons don't even make it to the target electrode.

The secret to the success of natural photosystems is the perfect fit of the individual components. The molecules fit precisely together like plugs and sockets and can pass electrons on directly and nearly without loss. The new approach taken by the Japanese researchers cleverly connects photosystem I (PSI) from the blue-green algae Thermosynechococcus elongatus with a synthetic apparatus. An important component of the electron transmission sequence of PSI is vitamin K1. The researchers removed the vitamin K1 from the PSI protein complex and replaced it with a synthetic analogue. This consists of three parts: 1) The same molecular "plug" with which vitamin K1 is bound to the protein complex (napthoquinone group) is used to "plug in" the synthetic binding component to PSI; 2) a molecular "wire" (hydrocarbon chain) with the same length as in vitamin K1 ensures that the binding component protrudes from the protein complex; and 3) at the other end of the wire is an additional "plug" (viologen group) that anchors the ensemble to a specially coated gold electrode. Electrons released by irradiation of PSI and transmitted along the wire are very efficiently transmitted to the gold electrode by the viologen group.

It may be possible to use this new strategy to integrate other biocomponents into synthetic systems.


'/>"/>

Contact: Nao Terasaki
nao-terasaki@aist.go.jp
Wiley-Blackwell
Source:Eurekalert  

Related biology news :

1. New molecular regulators of hyperthyroidism and goiter
2. Carnegie Mellon scientists investigate initial molecular mechanism that triggers neuronal firing
3. UC health news: molecular pathway may predict chemotherapy effectiveness
4. New molecular clock from LLNL and CDC indicates smallpox evolved earlier than believed
5. Story ideas from Molecular & Cellular Proteomics
6. Lets talk -- new paradigms in the research of the biomolecular composition of water
7. Scientists unveil structure of molecular target of many drugs
8. Potential new therapeutic molecular target to fight cancer
9. NIH selects LIAI for major study on allergy molecular causes and possible treatments
10. Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery
11. Leading cause of death in preemies might be controlled by resetting a molecular switch
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Plugging in molecular wires
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug ... Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( ... expected to deliver therapeutic levels of olanzapine for a period of 3 months., “We ...
(Date:2/24/2017)... , Feb. 24, 2017 Provectus Biopharmaceuticals, ... the "Company"), a clinical-stage oncology and dermatology biopharmaceutical ... deadline to participate in its previously announced rights ... of shares of common stock and Series C ... of listed warrants. As previously ...
(Date:2/24/2017)... 2017 Symic Bio, a biopharmaceutical company focused ... of therapeutics, announced today the completion of enrollment for ... disease. The trial will evaluate the safety and efficacy ... reduction of restenosis following angioplasty. "We,re ... SB-030," said Nathan Bachtell , M.D., Chief Medical ...
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
Breaking Biology Technology: